Rizatriptan Benzoate Odt Tablet, Orally Disintegrating
Product Images NDC 72189-609

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate Odt (NDC 72189-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189-609-18 (72189 609 18)

This is a description of medication in tablet form containing Rizatriptan Benzoate ODT 10 mg for the treatment of migraines. The tablets are generic for Maxalt and each tablet contains 14.53 mg of Rizatriptan Benzoate USP equivalent to 10 mg Rizatriptan. The medication is packaged and distributed by a pharmaceutical company based in Princeton, NJ. The lot sample should be discarded after the specified date, and the medication should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.